BlackRock Raises ChemoMetec Voting Rights to 15.08%
BlackRock notified ChemoMetec that it increased its voting rights attached to the company’s shares to 15.08% on Oct. 26, exceeding a reporting threshold under Danish law.
Related stories
Junshi Biosciences Q3 Revenue Rises 39.2%
Junshi Biosciences reported a 39.2% increase in revenue in its third-quarter report.
M impact | EQUITY | Oct 30, 2026, 02:25 AM UTC
Jakarta Stocks Fall 1.7%
M impact | EQUITY | Oct 30, 2026, 02:21 AM UTC
Indian Shares Seen Opening Higher After Earnings-Led Rebound
Indian shares are seen opening higher after an earnings-led rebound, with higher oil expected to cap gains.
M impact | EQUITY | Oct 30, 2026, 02:20 AM UTC
KHNP Seeks New Contractor for Czech Nuclear Project
KHNP is seeking a new contractor for its Czech nuclear project after talks collapsed.
M impact | EQUITY | Oct 30, 2026, 02:19 AM UTC
Alteogen Raises KRW 50 Billion in Preferred Share Private Placement
M impact | EQUITY | Oct 30, 2026, 02:19 AM UTC
Hyundai Mobis Q3 Operating Profit Rises 17.2%
Hyundai Mobis said third-quarter operating profit increased 17.2%. The headline also says Atlas parts prototype production is imminent.
M impact | EQUITY | Oct 30, 2026, 02:18 AM UTC